PeptidePicker
Home/Peptides/Cortagen
BioregulatorResearch

Cortagen

Also known as: Ala-Glu-Asp-Pro · AEDP

A tetrapeptide bioregulator for cerebral cortex modulation, used in neuro-recovery protocols after stroke and cognitive decay.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~30 minutes

Typical Dose

10 mg daily (oral, cycled)

Administration

Oral capsule

Mechanism of Action

Targets cortical neuron gene expression to halt cognitive decline, accelerate post-stroke recovery, and upregulate endogenous antioxidant defenses.

Key Research Areas

bioregulatorbraincortexstroke

Frequently Asked Questions

What is Cortagen?
A tetrapeptide bioregulator for cerebral cortex modulation, used in neuro-recovery protocols after stroke and cognitive decay.
How does Cortagen work?
Targets cortical neuron gene expression to halt cognitive decline, accelerate post-stroke recovery, and upregulate endogenous antioxidant defenses.
What is the recommended dosage for Cortagen?
The typical research dosage is 10 mg daily (oral, cycled), administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Cortagen?
The half-life of Cortagen is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Cortagen FDA approved?
Cortagen is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about Cortagen is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Bioregulator